American Medical Association (AMA)

The American Medical Association (AMA) is the largest professional association and lobbying group of physicians and medical students. The AMA mission is to promote the art and science of medicine and the betterment of public health. The association represents physicians with a unified voice in courts and legislative bodies across the nation, removing obstacles that interfere with patient care, leading efforts to prevent chronic disease and confront public health crises, and driving the future of medicine to tackle the biggest challenges in healthcare.

‘Concerning’ data connect industry payments to cardiologists with medical device use
U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned?
Confirmed: AFib ablation more beneficial for patients with HFrEF than those with HFpEF
Researchers explored data from nearly 2,500 AFib ablation patients, sharing their findings in JAMA Cardiology.
Donor hearts more likely to be accepted when the transplant candidate is female or white
"This finding suggests racial and gender bias as a potential contributor to the organ acceptance decision-making process," researchers wrote in JAMA.
Cardiologists received $1.3B in industry payments over 10-year period, No. 3 among all healthcare specialties
Only orthopedic surgeons and neurologists/psychiatrists received more industry payments from 2013 to 2022 than cardiologists. Also, the two prescription medications associated with the most physician payments were a blood thinner and an anticoagulant.
Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB
When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing.

older patient with a doctor at their house

Ross procedure still linked to ‘excellent’ outcomes as patients enter third decade after surgery

Researchers focused on more than 100 patients who underwent the Ross procedure from 1994 to 2001, sharing their findings in JAMA Cardiology.

November 9, 2023

artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

AI detects signs of AFib in asymptomatic patients

The study included ECG data from more than 900,000 U.S. veterans.

October 23, 2023

Overlapping concerns: 5 takeaways from a new study on CVD, CKD and type 2 diabetes among US adults

How common is it for patients to present with overlapping cardiac, renal and metabolic issues? A new analysis in JAMA Cardiology explored that very question.

September 28, 2023

Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD

Aspirin is known to be an effective, affordable way to prevent cardiovascular disease.

August 22, 2023

Cardiologists, cardiac surgeons support new bill that could limit Medicare cuts

More than 100 U.S. medical societies—including the ACC, ASNC and others—have united in support of a new bill that would make a long-term impact on Medicare payments.

April 24, 2023

A simple way to help cardiologists communicate with patients

A new JAMA Internal Medicine study suggests that communication coaching for cardiologists may help improve patient interactions by encouraging questions and increasing empathy.

April 14, 2023

U.S. News & World Report children’s hospitals cardiology heart surgery

Children with autism face higher risk of diabetes, heart disease, dyslipidemia

Researchers examined data from 34 different studies, publishing their full systematic review and meta-analysis in JAMA Pediatrics.

March 14, 2023

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more.

March 8, 2023

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

American Medical Association (AMA)

‘Concerning’ data connect industry payments to cardiologists with medical device use

Confirmed: AFib ablation more beneficial for patients with HFrEF than those with HFpEF

Donor hearts more likely to be accepted when the transplant candidate is female or white

Cardiologists received $1.3B in industry payments over 10-year period, No. 3 among all healthcare specialties

Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB

Around the web